The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.

Also called NCT06847568

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06847568
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06847568. Randomized; double masking; primary purpose prevention. Start 2024-04-01 (actual); primary completion 2026-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow
Condition
ST Segment Elevation Myocardial Infarction (STEMI)
Condition
No Reflow Phenomenon
Intervention (Drug)
Adrenaline
Lead sponsor
Ain Shams University (class: other)

Record details

Record id
cardio:ct-nct06847568
Content hash
a0e1cbe7cd0c552282cd874dc04d96ad4610bbe26469c5bd2ee713219a8830e9